We used an established isotope dilution gas chromatography-mass spectrometry method to measure blood volumes with an enriched stable isotope of chromium. The results were compared with those of the conventional method, which involves radioactive 51Cr The two methods were compared simultaneously in two male subjects of different sizes, and essentially identical volumes were obtained. The isotope dilution method is insensitive to contamination with natural (unenriched) chromium and can be used to measure all of the stable isotopes of chromium. The method has potential applications in simultaneous erythrocyte survival studies. The absence of radioactivity makes possible an accurate means of studying blood volume changes in children and during pregnancy.
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Indexing Terms: fetal status/pediatric chemistiy
The most widely used method of measuring blood volume relies on the irreversible binding of hexavalent chromium radiotracer (51Cr) to erythrocytes (RBCs); this method has also been used extensively in RBC survival studies.5 In this method, blood is removed, radiolabeled, and reinjected, and blood volume is calculated from the observed dilution of the radioactive tag. Radioisotopes cannot be used during pregnancy because this would expose mother and child to the radiation. However, it is extremely important to be able to measure blood volume accurately during pregnancy, to monitor its expansion.
Failure
of the blood volume to expand (preeclampsia) strikes 3-7% of all pregnant women and is associated with increased risk of death for both mother and child.
Chromium has four isotopes, with masses (and natural abundances) of 50(4.35%), 52 (83.8%), 53 (9.5%), and 54 amu (2.36%). Available electromagnetically enriched from Oak Ridge National Laboratory (Oak Ridge, TN), they are useful as tracers when measured by mass spectrometry or by neutron activation analysis (50Cr, n -, 51Cr, y). Several studies have measured RBC survival and RBC volume in humans (1) (2) (3) (4) (6) (7) (8) . Limitations are that a relatively large sample of RBCs must be used for the initial labeling, and any contamination of samples with natural chromium will cause errors in the measurements. An increasingly popular instrument that has potential for quick measurement of enriched stable isotopes of chromium for studies of this nature is a quadrupole mass spectrometer interfaced at atmospheric pressure with an inductively coupled plasma discharge in argon, which serves as the ionization source. RBC survival studies in horses were measured this way and compared with 51Cr radliotracer values (9). Although direct measurement in diluted RBCs is attractive, the presence of chlorine in cells produces molecular ion isobaric interferences at 52, 53, and 54 amu, and the 50Cr signal must be corrected for the presence of 50Ti in the samples. We chose for this study a robust chromium stable isotope method that has been in use in our laboratory for many years (10). A known quantity of enriched 50Cr is added to samples labeled with enriched 53Cr; the samples are then lyophilized, ashed, and dissolved, and the chromium is extracted as a thermally stable, volatile chelate. This is introduced into the ion source of a quadrupole mass spectrometer via a gas chromatograph (GC/MS). Individual molecular ions containing chromium are monitored and results quantitated by isotope ratio calculations. The method is sensitive (because all of the analyte is extracted from the sample), specific (combination of chelation, chromatography, and massspecific detection), precise, and insensitive to sample contamination with natural (unenriched) chromium.
Overall analysis time, for sample lyophilization, ashing, chelation, and measurement, is --4 days. The objective of this study is to demonstrate that blood volume measurements with enriched hexavalent 53Cr to tag RBCs give essentially the same results as the radioisotope method with 51Cr. This was done by using both isotopes simultaneously in two male volunteers of different sizes.
Materials and Methods

Apparatus.
The GCIMS system used for the analysis was a quadrupole mass spectrometer (Model 4000; Finnigan MAT, San Jose, CA) coupled to a gas chromatograph (Model 9610; Finnigan) and equipped with a programmable multiple-ion monitor. Three multipleion monitor channels were used to measure the chelate ion fragments corresponding to 50Cr, 52Cr, and 53Cr. Operating conditions were as follows: injector 165#{176}C; column 130#{176}C; transfer line and glass jet separator 175#{176}C; helium carrier gas flow rate 20 mLlmin. [-15 g of 53Cr(VI) ] was added slowly. The second bottle received 0.63 Ci of 51Cr(VI) per pound of the subject's weight (1.4 MCi/kg). The blood and the hexavalent Cr were allowed to incubate together with gentle mixing for 45 mm at room temperature. At the end of the incubation period, we added 100 mg of ascorbic acid (ACS reagent grade) to each bottle to reduce any unreacted Cr(VI) to Cr(III). A 19-gauge needle and two 10-mL syringes were again attached to a threeway stopcock. We drew 10 mL of the blood solution from one bottle into one syringe and 10 mL from the other bottle into the other syringe. The contents of one syringe and then the other were injected back into the subject. After 30 mm, two 10-mL blood samples were collected into evacuated tubes containing Li heparin as the anticoagulant from the arm opposite that used for injection. We determined microcentrifuged hematocrits on the blood solution from each vial and on the 30-mm wholeblood sample. Whole blood and plasma from each vial and from the 30-mm sample were saved for radioactive counting and (or) Cr isotopic analysis.
Isotopic analysis procedure.
We weighed plasma and whole-blood samples from the vial labeled with Cr and the 30-mm blood sample into acid-cleaned 16 x 100 mm These samples were then extracted with three or four 1-mL aliquots of hexane until the red-orange color of Fe-TFA was gone. We added 100 L of TFA to all the samples, tightly capped the tubes, and put the samples into a 75#{176}C multthole aluminum heating block for 1.5 h. The Cr-TFA complex was extracted with two or three 0.5-mL aliquots of hexane, which were combined. This hexane was then washed with 1-1.5 mL of 0.1 moIjL sodium hydroxide to remove unreacted TFA, and the samples were put into small vials. The samples were allowed to dry, reconstituted with 25 L of hexane, and sealed with caps that had Teflon-faced septa. The samples were not allowed to remain uncapped for long after drying because the Cr-TFA complex evaporates slowly at room temperature. We determined the concentration of 53Cr in the samples by isotopedilution, using the isotope ratios of 50/52 and 50/53 from the mass spectrometer, the original weight of the sample, and the weight of the internal standard. Radioactivity in the samples was counted in a well-type gamma counter.
Results and DIscussIon
The experiment in which whole-blood is removed, the RBCs labeled with hexavalent chromium, a portion of the whole-blood reiiijected, and a sample taken for estimation of blood volume by dilution of the tracer gives a direct measure of whole-blood volume. With a tracer such as 51Cr or 53Cr, which can be designated as whole-blood volume can be expressed as: (1) The stable isotopemethodology for these measurements is well established, and the necessary instrumentation is available in many laboratories, and the equipment is not overly expensive.
